| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $0.86 (Beat by $0.14) |
| EPS GAAP Actual | $0.86 (Beat by $0.14) |
| Revenue Actual | $1.62175B |
| Revenue Surprise | Beat by $1621.75M |
| Announce Date | 03/29/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.77619 |
| EPS GAAP Estimate | $0.77619 |
| Revenue Estimate | $1.577147261B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 0 | INF | 0 | 0 | 2 |
| Dec 2027 | 4.75 | 12.7 | 4.54937 | 5.04631 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.6 | 0.6 | 1.62175B | -11.62% | 1621.75M |
| FQ2 2025 (Jun 2025) | 0.52 | 0.52 | 1.58432B | -5.44% | 1584.32M |
| FQ1 2025 (Mar 2025) | 0.62 | 0.62 | 1.55436B | 1.2% | 1554.36M |
| FQ1 2017 (Mar 2017) | 0.19 | 0.19 | 0.733599B | 100% | 733.6M |
| FQ2 2017 (Jun 2017) | 0.22 | 0.22 | 0.737979B | 100% | 737.98M |
| FQ3 2017 (Sep 2017) | 0.3 | 0.3 | 0.728918B | 100% | 728.92M |
| FQ4 2017 (Dec 2017) | 0.27 | 0.27 | 0.816515B | 100% | 816.52M |
| FQ4 2024 (Dec 2024) | 0.48 | 0.48 | 1.73432B | 13.84% | 1734.32M |
FQ4 Announce Date
03/29/2026 (Pre-Market)
Consensus EPS Estimates
0.77619
Consensus Revenue Estimates
1.577147261B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.0644 | -- | 0.97686 | 1.15764 | 2 |
| FQ3 2027 (Sep 2027) | 1.02059 | -- | 0.93665 | 1.10999 | 2 |
| FQ2 2027 (Jun 2027) | 0.97041 | -- | 0.8906 | 1.05541 | 2 |
| FQ1 2027 (Mar 2027) | 0.91739 | -- | 0.84194 | 0.99775 | 2 |
| FQ4 2026 (Dec 2026) | 0.93151 | -- | 0.8549 | 1.01311 | 3 |
| FQ3 2026 (Sep 2026) | 0.90554 | 33.74 | 0.83106 | 0.98486 | 3 |
| FQ2 2026 (Jun 2026) | 0.83491 | 37.72 | 0.76624 | 0.90804 | 3 |
| FQ1 2026 (Mar 2026) | 0.77619 | 20.12 | 0.66673 | 0.8757 | 6 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.99B | -- | 1.86B | 2.12B | 2 |
| FQ3 2027 (Sep 2027) | 1.9B | -- | 1.78B | 2.03B | 2 |
| FQ2 2027 (Jun 2027) | 1.83B | -- | 1.72B | 1.96B | 2 |
| FQ1 2027 (Mar 2027) | 1.76B | -- | 1.64B | 1.87B | 2 |
| FQ4 2026 (Dec 2026) | 1.77B | -- | 1.65B | 1.89B | 2 |
| FQ3 2026 (Sep 2026) | 1.73B | 6.06 | 1.62B | 1.84B | 2 |
| FQ2 2026 (Jun 2026) | 1.65B | 4.05 | 1.55B | 1.76B | 2 |
| FQ1 2026 (Mar 2026) | 1.58B | 1.44 | 1.44B | 1.7B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.6 | 0.6 | 100% | |
| FQ2 2025 (Jun 2025) | 0.52 | 0.52 | 100% | |
| FQ1 2025 (Mar 2025) | 0.62 | 0.62 | 100% | |
| FQ1 2017 (Mar 2017) | 0.19 | 0.19 | 100% | |
| FQ2 2017 (Jun 2017) | 0.22 | 0.22 | 100% | |
| FQ3 2017 (Sep 2017) | 0.3 | 0.3 | 100% | |
| FQ4 2017 (Dec 2017) | 0.27 | 0.27 | 100% | |
| FQ4 2024 (Dec 2024) | 0.48 | 0.48 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $1.62B | $1621.75M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $1.58B | $1584.32M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.55B | $1554.36M | 100% |
| FQ1 2017 (Mar 2017) | $0B | $0.73B | $733.6M | 100% |
| FQ2 2017 (Jun 2017) | $0B | $0.74B | $737.98M | 100% |
| FQ3 2017 (Sep 2017) | $0B | $0.73B | $728.92M | 100% |
| FQ4 2017 (Dec 2017) | $0B | $0.82B | $816.52M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.73B | $1734.32M | 100% |